In this edition, you’ll read about our advocacy work, calling on the Federal Government to delay proposed Medicare changes that could have increased out-of-pocket costs for sight-saving eye injections.
We’re thrilled to share that on March 6 the Government confirmed it will not proceed with these changes. This is a significant win for the macular disease community.
This edition also covers geographic atrophy (late-stage dry AMD), including updates on newly approved treatments that may help slow disease progression, and emerging research exploring innovative technologies to improve vision.
As we celebrate 25 years, we also look to the future. Over the past quarter of a century, the Foundation has grown alongside the community it serves — and what has remained constant is our commitment to ensuring people affected by macular disease feel informed, supported, and never alone.
Thank you for being part of this remarkable community. We hope you enjoy this edition of Vision Voice and continue to stand alongside us as we enter our next 25 years.
You can download the newsletter here on our website or listen to the audio version – whichever suits you best. If you have any questions about the newsletter or need support, please call our National Helpline on 1800 111 709.
Download
Community action keeps eye injections accessible for people with private health insurance
On Friday 6 March 2026, the Federal Health Minister, the Hon. Mark Butler MP, announced